Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Evenity
Evenity
Amgen faces patent infringement claims on big-selling osteoporosis drug Evenity
Fierce Pharma
Tue, 04/25/23 - 10:10 pm
Amgen
legal
patents
osteoporosis
Evenity
OssiFi-Mab
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Xconomy
Thu, 12/12/19 - 11:02 am
osteoporosis
Amgen
Europe
romosozumab
Evenity
Amgen/UCB hit another Evenity hurdle, as European regulators fail to back the osteoporosis drug
Endpoints
Fri, 06/28/19 - 10:04 am
Amgen
UCB Pharma
FDA
EMA
Europe
osteoporosis
Evenity
romosozumab
Amgen prices bone builder Evenity at $21,900/year to compete on convenience, not cost
Endpoints
Tue, 04/16/19 - 09:50 am
Amgen
osteoporosis
Evenity
drug pricing
FDA approves Evenity for osteoporosis
BioCentury
Tue, 04/9/19 - 07:03 pm
FDA
Evenity
romosozumab
Amgen
UCB Pharma
osteoporosis
Amgen's once-dismissed osteoporosis drug Evenity 'back in the game' after rosy FDA panel vote
Fierce Pharma
Thu, 01/17/19 - 12:06 am
Amgen
osteoporosis
Evenity
romosozumab
FDA
advisory panels